1. Home
  2. NAMS vs NSA Comparison

NAMS vs NSA Comparison

Compare NAMS & NSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • NSA
  • Stock Information
  • Founded
  • NAMS 2019
  • NSA 2013
  • Country
  • NAMS Netherlands
  • NSA United States
  • Employees
  • NAMS N/A
  • NSA N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • NSA Real Estate Investment Trusts
  • Sector
  • NAMS Health Care
  • NSA Real Estate
  • Exchange
  • NAMS Nasdaq
  • NSA Nasdaq
  • Market Cap
  • NAMS 2.7B
  • NSA 3.2B
  • IPO Year
  • NAMS N/A
  • NSA 2015
  • Fundamental
  • Price
  • NAMS $18.57
  • NSA $37.74
  • Analyst Decision
  • NAMS Strong Buy
  • NSA Hold
  • Analyst Count
  • NAMS 7
  • NSA 9
  • Target Price
  • NAMS $41.33
  • NSA $43.06
  • AVG Volume (30 Days)
  • NAMS 646.5K
  • NSA 377.5K
  • Earning Date
  • NAMS 03-04-2025
  • NSA 02-26-2025
  • Dividend Yield
  • NAMS N/A
  • NSA 6.04%
  • EPS Growth
  • NAMS N/A
  • NSA 71.81
  • EPS
  • NAMS N/A
  • NSA 1.83
  • Revenue
  • NAMS $33,594,000.00
  • NSA $786,922,000.00
  • Revenue This Year
  • NAMS $131.53
  • NSA N/A
  • Revenue Next Year
  • NAMS N/A
  • NSA $1.02
  • P/E Ratio
  • NAMS N/A
  • NSA $20.65
  • Revenue Growth
  • NAMS 78.77
  • NSA N/A
  • 52 Week Low
  • NAMS $15.19
  • NSA $34.50
  • 52 Week High
  • NAMS $27.29
  • NSA $49.44
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 29.65
  • NSA 50.88
  • Support Level
  • NAMS $18.88
  • NSA $37.26
  • Resistance Level
  • NAMS $20.46
  • NSA $38.57
  • Average True Range (ATR)
  • NAMS 1.11
  • NSA 0.67
  • MACD
  • NAMS -0.09
  • NSA 0.12
  • Stochastic Oscillator
  • NAMS 5.84
  • NSA 64.07

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About NSA National Storage Affiliates Trust of Beneficial Interest

National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, Northwest and Move It brands.

Share on Social Networks: